Bio Solution Co.,Ltd. (KOSDAQ:086820)

Market Cap	232.62B
Revenue (ttm)	8.27B
Net Income (ttm)	-1.28B
Shares Out	24.13M
EPS (ttm)	-53.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	94,246
Average Volume	226,135
Open	10,590
Previous Close	10,560
Day's Range	10,000 - 10,590
52-Week Range	3,903 - 13,200
Beta	0.78
RSI	36.99
Earnings Date	n/a

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086820